We are live on
!
Find out more
MPAM
Murphy Pohlad Asset Management Portfolio holdings
AUM
$287M
1-Year Est. Return
38.81%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+38.81%
3 Year Est. Return
+75.1%
5 Year Est. Return
+92.69%
10 Year Est. Return
+345.55%
AUM
$131M
AUM Growth
-$7.89M
(-5.7%)
Cap. Flow
-$6.32M
Cap. Flow
% of AUM
-4.84%
Top 10 Holdings %
Top 10 Hldgs %
27.88%
Holding
95
New
1
Increased
18
Reduced
34
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CHK
Chesapeake Energy Corporation
CHK
|
+$1.12M |
| 2 |
Diageo
DEO
|
+$978K |
| 3 |
IBM
IBM
|
+$817K |
| 4 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$807K |
| 5 |
Bank of America
BAC
|
+$636K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$2.73M |
| 2 |
Pfizer
PFE
|
+$1.76M |
| 3 |
3M
MMM
|
+$1.69M |
| 4 |
Generac Holdings
GNRC
|
+$816K |
| 5 |
DD
Du Pont De Nemours E I
DD
|
+$432K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.74% |
| 2 | Consumer Staples | 15.86% |
| 3 | Healthcare | 11.94% |
| 4 | Technology | 11.11% |
| 5 | Energy | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
The Mosaic Company
MOS
$7.33B
| $288K | 0.22% |
6,255
| – | – |
|
77
Bristol-Myers Squibb
BMY
$132B
| $283K | 0.22% |
4,403
| – | – |
|
78
AbbVie
ABBV
$435B
| $248K | 0.19% |
4,237
| – | – |
|
79
Markel Group
MKL
$23.2B
| $227K | 0.17% |
296
| – | – |
|
80
Northern Trust
NTRS
$33.9B
| $225K | 0.17% |
3,236
| – | – |
|
81
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $224K | 0.17% |
4,250
| – | – |
|
82
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
| $219K | 0.17% |
1,790
| – | – |
|
83
Genuine Parts
GPC
$18.7B
| $217K | 0.17% |
2,336
| – | – |
|
84
Murphy Oil
MUR
$4.78B
| $217K | 0.17% |
4,660
| – | – |
|
|
MRO
85
DELISTED
Marathon Oil Corporation
MRO
| $217K | 0.17% |
8,326
| – | – |
|
86
CVS Health
CVS
$122B
| $214K | 0.16% |
2,075
-250
| -11% | -$25.3K |
|
87
Sysco
SYY
$40.3B
| $213K | 0.16% |
5,648
-8,415
| -60% | -$332K |
|
88
TSMC
TSM
$2.18T
| $209K | 0.16% |
+8,906
| New | +$210K |
|
89
Ovintiv
OVV
$16.4B
| $117K | 0.09% |
2,099
-559
| -21% | -$35.2K |
|
90
Arthur J. Gallagher & Co
AJG
$63.6B
| – | – |
-4,500
| Closed | -$211K |
|
91
GSK
GSK
$106B
| – | – |
-3,815
| Closed | -$203K |
|
92
Eli Lilly
LLY
$1.06T
| – | – |
-3,336
| Closed | -$230K |
|
|
93
Medtronic
MDT
$112B
| – | – |
-37,819
| Closed | -$2.73M |
|
94
SiriusXM
SIRI
$10.1B
| – | – |
-1,000
| Closed | -$35K |
|
|
DD
95
DELISTED
Du Pont De Nemours E I
DD
| – | – |
-6,160
| Closed | -$432K |
|
Similar funds
EA
GCM
PAM
MM
FCG
AWM
MAG
A
Murphy Pohlad Asset Management's Q1 2015 Portfolio in Review
As of Q1 2015, Murphy Pohlad Asset Management held 95 positions worth $131M, down 5.7% from $138M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Murphy Pohlad Asset Management withdrew a net $6.32M in Q1 2015, closing 6 positions and reducing 34 holdings. Its most notable exit was Medtronic, an estimated $2.73M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Consumer Staples and Healthcare.
Against the trend, Murphy Pohlad Asset Management opened a new position in TSMC worth $209K.
- Murphy Pohlad Asset Management's largest Q1 2015 buy was TSMC: 8,906 shares worth $209K.
- Murphy Pohlad Asset Management added most to Chesapeake Energy Corporation in Q1 2015, an estimated $1.12M increase.
- Murphy Pohlad Asset Management's biggest Q1 2015 reduction was Pfizer, cutting an estimated $1.76M.
- Murphy Pohlad Asset Management fully exited Medtronic in Q1 2015, selling an estimated $2.73M.
- Murphy Pohlad Asset Management's ten largest holdings make up 28% of its $131M portfolio in Q1 2015.
- Murphy Pohlad Asset Management opened 1 new position and closed 6 in Q1 2015.
- Murphy Pohlad Asset Management's portfolio value fell 5.7% quarter-over-quarter to $131M.
Based on Murphy Pohlad Asset Management's 13F filing for Q1 2015, filed 16 Apr 2015.